期刊文献+

甲磺酸加替沙星葡萄糖注射液治疗急性细菌性感染随机对照临床研究 被引量:1

A Radomized Control Clinical Trial of Gatifloxacin Injection with Glucose in Treatment of Acute Bacterial Infection
下载PDF
导出
摘要 目的 :评价甲磺酸加替沙星葡萄糖注射液治疗急性细菌性感染的有效性和安全性。方法 :采用区组分层均衡随机单盲试验设计 ,完成甲磺酸加替沙星葡萄糖注射液 2 1例及盐酸左氧氟沙星注射液 19例共 4 0例感染患者的临床试验。结果 :试验组对照组病例的一般项目基本相似 ,甲磺酸加替沙星葡萄糖注射液与左氧氟沙星注射液的临床有效率分别为 95 2 3%和 89 4 7% ,细菌学有效率分别为 94 74 %和 87 5 0 % ,细菌清除率为 10 0 %和93 75 % ,不良反应发生率分别为 4 76 %、 0 ,不良反应轻微 ,无需处理 ,自行复常。结论 :甲磺酸加替沙星葡萄糖注射夜是一种安全有效的广谱抗菌药物 ,抗菌活性强 ,可用于治疗多种细菌引起的感染。 Objective:To evaluate the clinical efficacy and safety of gatifloxacin injection with glucose in treatment of acute bacterial infection.Method:A randomized,simgle blind controlled clinical design was used do accomplish the clinical trial included 21 cases in gatifloxation group and 19 cases in levofloxacin group.Result:The common data of patients in the two groups were similar,the clinical effective rates of gatifloxation and levofloxacin in the were 95.23% and 89.47%,bacteriological effective rates were 94.74% and 87.50%,bacteria eradicate rates were 100% and 93.75%,the rates of adverse reaction in two groups 4.76% and 0.Conclusion:Gatifloxacin injection is a effective and safety antimicrobial agents for acute bacteria infections,which have powerful antibatria activity for various bacteria.It may used to treat various infections due to many bacteria.
出处 《华西医学》 CAS 2004年第2期230-232,共3页 West China Medical Journal
关键词 甲磺酸加替沙星葡萄糖注射液 药物治疗 急性细菌性感染 有效性 安全性 左氧氟沙星注射液 Gatifloxation Levofloxacin randomized controlled clinical trial
  • 相关文献

参考文献7

  • 1Richard GA,Mathew CP,Kirstein JM,et al.Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women:results from a randomized,double -blind,multi-center trial comparing single-dose to 3-day fluoroquinolone regimens[J].Urolog
  • 2Cox CE,Marbury TC,Pitman WG,et al.Arandomized,double-blind,multi-center compaarison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis[J].[abstract]Clin Ther,2002;24(2):223.
  • 3Wakabayshi E,Mitsuhashi S.In vitro antibacterial activity of AM-1155.novel 6-fluoro-8-methoxy quinolone[J].Antimicrob Agents Chemother.1994;38(3):594.
  • 4Soler N,Lode H,Baldwin R,et al.Radomised Double-Blind Comparisison of Oral Gatifloxacin and Co-amoxiclav for Acute Exacerbation of Chronic Bronchitis[J].Eur J Clin Microbiol Infection DIS 2003;22(3):144-50.
  • 5Perry CM,Balfour JAB,Lamb HM[J].Catifoxacin.Drugs,1999;58(683).
  • 6李家泰,刘健,王彤,朱琪,刘燕.盐酸加替沙星(Gatifloxacin)体外抗菌作用[J].中国临床药理学杂志,2001,17(6):403-409. 被引量:40
  • 7张能江,张淑华,庄镇华.加替沙星对金黄色葡萄球菌的体外抗菌活性[J].中国抗生素杂志,2002,27(12):753-755. 被引量:6

二级参考文献8

  • 1[1]Hosaka M,Yaxue T, Fukuda H, Tomizawa H, et al.In vitro and in vivo antibacterial activities of AM-1 155, a new 6-fluoro-8-methoxy quinolone. Antimicrobial Agents Chemotherapy, 1992;36:2108~2117.
  • 2[2]Wakabayashi E, Mitsuhashi S. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methyoxy quinolone. Antimicrobial Agents Chemotherapy, 1994;38:594~601.
  • 3[3]Wise R, Brenwald NP, Andrews JM,et al. The activity of the methylpiperazinyl fluoroquinolone CG5501:A comparison with other fluoroquinolones fluoroquinolones. Antimicrobial Chemotherapy, 1997;39:447~452.
  • 4[4]National Committee for Clinical Laboratory Standards. 1998;18.
  • 5[5]Hosaka M,Kinoshita S, Toyama A,et al. Antibacterial Properties of AM-1155, a new 8-methoxy quinolone. Antimicrobial Chemotherapy, 1995; 36:293~301.
  • 6[6]Tanaka M,Takahashi K, Saika T, et al. Development of fluoroquinoloneresistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae in Japan. Urology, 1998; 159:2215~2219.
  • 7[7]Deguchi T, Yasuda M, Nakano M,ea al. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GryA and ParC.Chemotherapy, 1997;43:239~244.
  • 8[8]Nakashima M,Uematsu T,Kosuge K, et al. Single and multiple-dose pharmacolinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrobial Agents Chemotherapy,1995;39:2635~2640.

共引文献40

同被引文献57

引证文献1

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部